Biotechnology
Abortion providers rush to make backup plans as Supreme Court decides whether to keep limits on mifepristone
U.S. abortion pill providers are scrambling to make backup plans as the Supreme Court decides whether to keep restrictions on the key drug mifepristone. Some in-person clinics in New York, California and Kansas will offer mifepristone for now, but are preparing to provide an alternative abortion pill if a subsequent decision essentially bans the drug. […]
Read More
Supreme Court lifts abortion pill restrictions for now
U.S. Supreme Court Justice Samuel Alito on Friday temporarily blocked lower court rulings that imposed tighter restrictions on the abortion pill mifepristone. U.S. Judge Matthew Kacsmaryk of the U.S. Northern District of Texas suspended the Food and Drug Administration’s approval of mifepristone last week. The U.S. 5th Circuit Court of Appeals blocked that part of […]
Read More
Supreme Court asked to block ruling that threatens access to abortion pill mifepristone
In this photo illustration, packages of Mifepristone tablets are displayed at a family planning clinic on April 13, 2023 in Rockville, Maryland. Anna Moneymaker | Getty Images The Justice Department and the abortion pill distributor Danco Laboratories on Friday asked the Supreme Court to block an order that threatens access to mifepristone. The U.S. 5th […]
Read More
Florida House passes six-week abortion ban backed by DeSantis
The Florida House of Representatives on Thursday passed legislation that would ban most abortions after six weeks, when many women don’t know they are pregnant. The bill passed by a vote of 70 to 40, largely along party lines. The measure now goes to Florida Gov. Ron DeSantis, who is expected to sign it into […]
Read More
Key court ruling does not restrict abortion pill access in 17 states, Washington state AG says
Mifepristone (Mifeprex), one of the two drugs used in a medication abortion, is displayed at the Women’s Reproductive Clinic, which provides legal medication abortion services, in Santa Teresa, New Mexico, on June 15, 2022. Robyn Beck | AFP | Getty Images Abortion pill mifepristone will remain fully available in more than a dozen states with […]
Read More
Blocking FDA approval of abortion pill could stifle innovation in the biopharma industry, experts say
A messy legal fight over the Food and Drug Administration’s approval of the abortion pill mifepristone poses risks to the biopharma industry that go beyond the single drug. If a subsequent decision tosses out the pill’s approval, it could potentially stifle innovation in the sector and deter investments in the development of life-changing drugs, biopharma […]
Read More
Key court ruling does not restrict abortion pill access in 17 states, Washington state AG says
Mifepristone (Mifeprex), one of the two drugs used in a medication abortion, is displayed at the Women’s Reproductive Clinic, which provides legal medication abortion services, in Santa Teresa, New Mexico, on June 15, 2022. Robyn Beck | AFP | Getty Images The abortion pill mifepristone will remain fully available in more than a dozen states […]
Read More
U.S. appeals court allows abortion pill mifepristone to stay on the market but blocks mail delivery
In this 2018 photo, mifepristone and misoprostol pills are provided at a Carafem clinic for medication abortions in Skokie, Illinois. Erin Hooley | Tribune News Service | Getty Images A federal appeals court has allowed the abortion pill mifepristone to remain on the U.S. market for now, but it imposed major restrictions on the medication […]
Read More
House Democrats call for immediate hearing on Texas abortion pill ruling
Abortion rights advocates gather in front of the J Marvin Jones Federal Building and Courthouse in Amarillo, Texas, on March 15, 2023. Moises Avila | AFP | Getty Images Democrats on the U.S. House Committee on Energy and Commerce on Wednesday requested an immediate hearing on a federal judge’s order suspending the Food and Drug […]
Read More
Juul to pay $462 million to settle youth vaping claims from six states, D.C.
Juul will pay $462 million to settle claims by six states and Washington D.C. that the vaping company marketed its addictive e-cigarettes to underage teens, five Democratic attorneys general announced Wednesday. Those states are New York, California, Massachusetts, New Mexico, Illinois and Colorado. New York alone will receive $112.7 million over an eight-year period. “There […]
Read More